We are live on ! Find out more
CORT icon

Corcept Therapeutics
CORT

207 hedge funds and large institutions have $1.26B invested in Corcept Therapeutics in 2018 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 86 increasing their positions, 64 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 64

1.21% more ownership

Funds ownership: 76.01% → 77.22% (+1.2%)

4% less funds holding

Funds holding: 215 → 207 (-8)

9% less capital invested

Capital invested by funds: $1.38B → $1.26B (-$121M)

21% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 34

46% less call options, than puts

Call options by funds: $6.35M | Put options by funds: $11.8M

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
207
Holders Change
-8
Holders Change %
-3.72%
% of All Funds
4.73%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
27
Increased
86
Reduced
64
Closed
34
Calls
$6.35M
Puts
$11.8M
Net Calls
-$5.46M
Net Calls Change
+$11.4M

Top Buyers

1
BlackRock
BlackRock
New York
+$21.6M
2
ISL
Ingalls & Snyder LLC
New York
+$15.1M
3
Invesco
Invesco
Georgia
+$13.4M
4
Morgan Stanley
Morgan Stanley
New York
+$9.96M
5
Stifel Financial
Stifel Financial
Missouri
+$6.63M

Top Sellers

1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$19M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$13.4M
3
JIM
Jupiter Investment Management
United Kingdom
-$7.9M
4
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
-$6.89M
5
NC
Nexthera Capital
New York
-$5.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
TWA
201
TCI Wealth Advisors
Arizona
$1K – – –
PFBT
202
Parkside Financial Bank & Trust
Missouri
$1K +$126 +9 +17%
SWP
203
Stratos Wealth Partners
Ohio
$1K +$797 +57 New
US Bancorp
204
US Bancorp
Minnesota
$1K +$1.24K +89 New
WSTAM
205
Wilbanks Smith & Thomas Asset Management
Virginia
$1K +$1.4K +100 New
RCAG
206
Rehmann Capital Advisory Group
Michigan
$715 -$1.9K -136 -73%
Arrowstreet Capital
207
Arrowstreet Capital
Massachusetts
– -$13.4M -849,978 Closed
JIM
208
Jupiter Investment Management
United Kingdom
– -$7.9M -502,429 Closed
Fuller & Thaler Asset Management
209
Fuller & Thaler Asset Management
California
– -$6.89M -438,342 Closed
NC
210
Nexthera Capital
New York
– -$5.27M -335,177 Closed
DA
211
Denali Advisors
California
– -$3.55M -225,600 Closed
HSA
212
Hussman Strategic Advisors
Maryland
– -$1.97M -125,000 Closed
NA
213
Navellier & Associates
Nevada
– -$1.79M -114,041 Closed
SI
214
Shaker Investments
Ohio
– -$1.69M -107,640 Closed
3C
215
361 Capital
Colorado
– -$1.68M -107,073 Closed
Allianz Asset Management
216
Allianz Asset Management
Germany
– -$1.55M -98,450 Closed
TCM
217
Timpani Capital Management
Wisconsin
– -$1.27M -80,568 Closed
CI
218
Cavalier Investments
Georgia
– -$1.19M -76,000 Closed
CIP
219
Convergence Investment Partners
Florida
– -$1.17M -74,357 Closed
MWNA
220
Marshall Wace North America
New York
– -$1.02M -65,012 Closed
1CM
221
1492 Capital Management
Wisconsin
– -$1.01M -64,429 Closed
CAM
222
ClariVest Asset Management
California
– -$969K -61,649 Closed
Squarepoint
223
Squarepoint
New York
– -$912K -57,997 Closed
CIC
224
Cornercap Investment Counsel
Georgia
– -$700K -44,555 Closed
SO
225
STRS Ohio
Ohio
– -$558K -39,900 Closed
6 7 8
9
10

CORT Hedge Fund Activity: Q3 2018 in Review

207 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Corcept Therapeutics (CORT) for Q3 2018, worth a combined $1.26B — down 8.8% from $1.38B a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of CORT and 27 opened new positions — a net loss of 7 holders — while 64 trimmed existing stakes and 86 added.

The largest buyer was BlackRock, adding an estimated $21.6M. The largest seller was Acadian Asset Management, cutting an estimated $19M.

  • 207 institutional investors held Corcept Therapeutics (CORT) as of Q3 2018, down from 215 in Q2 2018.
  • Funds reported $1.26B of Corcept Therapeutics stock for Q3 2018, down 8.8% quarter-over-quarter.
  • 27 funds opened new Corcept Therapeutics positions in Q3 2018 and 34 closed out, a net change of -7 holders.
  • The largest Corcept Therapeutics buyer in Q3 2018 was BlackRock, an estimated $21.6M added.
  • The largest Corcept Therapeutics seller in Q3 2018 was Acadian Asset Management, an estimated $19M sold.

Based on aggregated 13F filings for Q3 2018.